The Gambia has already started withdrawing The company said it followed Indian health protocols and was
The ANI news agency Maiden said it was shocked and saddened Maiden Pharmaceuticals had failed to provide guarantees about their products' safety, the Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. The products are Promethazine Oral Solution, Pain, vomiting, diarrhoea, inability to pass urine, headache and acute kidney The toxic substances allegedly contained in the cough syrups include abdominal
Warned Nigerians to avoid the said syrups and report any "suspicion of adverseĭrug reaction and substandard and falsified medicines". Our internal surveillance mechanisms to mop up these products from the supplyĬhain pipeline if they are ever found," the agency said. Of these spurious products from the various ports of entry and have activated Nevertheless, the authorities have put "appropriate measures in place to prevent entry The regulatory agency also added that the four paediatric medicines have notīeen registered in Nigeria, therefore they should not be in the country. Spokesperson for the agency, Sayo Akintola told the BBC that the agency’s "surveillance up to date has not found the controversial drugs in the Nigerian Indian company, Maiden Pharmaceuticals, have not been found in Nigeria. Nigeria’s National Agency for Food and DrugĪdministration and Control (Nafdac) says the medicines manufactured by an Importation into the country of cough syrups linked to the deaths of 69 children in The Gambia. Nigerian authorities say they are intensifying surveillance to prevent the
Getty Images Copyright: Getty Images Supervision over the manufacture of medicines in India has been called into question Image caption: Supervision over the manufacture of medicines in India has been called into question
0 kommentar(er)
